CGEM

CGEM Operating Cash Flow (Statement)

-$159.25MTTM · USD

Period ending:

CGEM FY Cash from OperationsUSD
CGEM FY Cash from Operations2018-12-31: -$13.55M2019-12-31: -$20.90M2020-12-31: -$29.77M2021-12-31: -$43.43M2022-12-31: -$126.66M2023-12-31: -$134.28M2024-12-31: -$145.30M2025-12-31: -$175.75M$0.00-$175.75M
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CGEM operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Cullinan Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-175,750,000
-145,303,000
-134,275,000
-126,664,000
-43,433,000
-29,772,000
-20,897,000
-13,549,000

Compare operating cash flow (statement)

All CGEM financial metrics · CGEM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.